Deuremidevir Hydrobromide for Suspension
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Deuremidevir Hydrobromide for Suspension, covering 2024-10-01 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV [Phase 2]